Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 151

Sort by

Sort Order Select

Journal Articles

Co-mutation of BCOR and BCORL1 was associated with favorable outcome in the adverse risk patients with Acute Myeloid Leukemia

Shunjie Yu, Zongru Li, Lijuan Hu, Ya-Zhen Qin, Guorui Ruan, Yazhe Wang, Hao Jiang, Feifei Tang, Jinsong JIA, Jing Wang, Qiang Fu, Xiaohui Zhang, Lanping Xu, Yu Wang, Yuqian Sun, Yueyun Lai, Hong-Xia Shi, Xiaojun Huang, Qian Jiang

Blood (2025) 146 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2025-3400

Published: 2025

Journal Articles

Orelabrutinib combined with short-course bendamustine-rituximab (BR) for first-line treatment of chronic lymphocytic leukemia: A prospective multicenter study

Linlin Cao, Hao Song, Guolin Wu, Hu Mao Gui, Qiang Xu, CuiCui Wang, Dandan Fan, Yuanyuan Feng, ChenYang Zhou, Jing Ming, Xinchen Wang, Jing Wang, Meiqi Ding, Youzhi Wu, Long Zhong, Kaiyang Ding

Blood (2025) 146 (Supplement 1): 2127.

https://doi.org/10.1182/blood-2025-2127

Published: 2025

Journal Articles

JAK1/2 inhibition with ruxolitinb potentiates ex vivo activity of epcoritamab in primary CLL cells

Xiao Lyu, Stephanie Chamberlain, Jeremy Zhang, Jing Wang, Nathalie Javidi-Sharifi, Matthew S Davids

Blood (2025) 146 (Supplement 1): 2106.

https://doi.org/10.1182/blood-2025-2106

Published: 2025

Journal Articles

CD47-blockade induces programmed necroptosis and complements the effects of BCL-2 inhibition in lymphoid malignancies

Blood (2025) 146 (Supplement 1): 1525.

https://doi.org/10.1182/blood-2025-1525

Published: 2025

Journal Articles

Phase I study of a CD19-directed CAR-T cell therapy for Relapsed/refractory mantle cell lymphomas(MCL)

Ping Yang, Jinjie Gao, Lan Luo, Weilong Zhang, Jing Wang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 7125.

https://doi.org/10.1182/blood-2025-7125

Published: 2025

Journal Articles

Efficacy and safety of first-line orelabrutinib combined with obinutuzumab (With or Without Bendamustine) in high-risk marginal zone lymphoma: Results from the orchid study

Hu Mao Gui, Jing Ming, Jing Wang, Guolin Wu, Dandan Fan, Yuanyuan Feng, Xinchen Wang, Linlin Cao, Hao Song, CuiCui Wang, Qiang Xu, ChenYang Zhou, Kaiyang Ding

Blood (2025) 146 (Supplement 1): 3597.

https://doi.org/10.1182/blood-2025-3597

Published: 2025

Journal Articles

Genomic characterization uncovers molecular subtypes in Mantle Cell Lymphoma

Changjian Yan, Ping Yang, Jie Chen, Chaoling Wu, Xiaoyu Hao, Jing Wang, Mingxia Zhu, Yan Liu, Weilong Zhang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 3590.

https://doi.org/10.1182/blood-2025-3590

Published: 2025

Journal Articles

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma

Shuozi Liu, Ping Yang, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Hongmei Jing

Blood (2025) 146 (Supplement 1): 3589.

https://doi.org/10.1182/blood-2025-3589

Published: 2025

Journal Articles

Efficacy and safety of iptacopan in paroxysmal nocturnal hemoglobinuria (PNH): A real-world study of 35 patients from anhui, China

Ziwei Zhou, Fengbo Jin, Li Ye, Xin Sun, Jing Wang, Xiaoxing Sun, Yiming Zhao, Yan Dai, Lingsu Gao, Binbin Jiang, Qichuan Jin, Yuehong Li, Qinhua Liu, Qinqin Zhao, Shengneng Tao, Xiaoyu Zhu

Blood (2025) 146 (Supplement 1): 6538.

https://doi.org/10.1182/blood-2025-6538

Published: 2025

Journal Articles

Inhibition of PRMT5 with JNJ-64619178 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptosis

Fen Zhu, Jing Wang, Christine Ryan, Liam Hackett, Jeremy Zhang, Stephen Chong, Matthew S Davids

Blood (2025) 146 (Supplement 1): 5076.

https://doi.org/10.1182/blood-2025-5076

Published: 2025

Journal Articles

Efficacy and safety of zanubrutinib combined with reduced-dose bendamustine and Rituximab for eldly Mantle Cell Lymphoma: A retrospective analysis

Ping Yang, Shuozi Liu, Chuanyuan Li, Lan Luo, Weilong Zhang, Jing Wang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 7097.

https://doi.org/10.1182/blood-2025-7097

Published: 2025

Journal Articles

Apoptotic rewiring via PI3K hyperactivation as a therapeutic strategy in B-cell malignancies

Stephen Martindale, Etienne Leveille, Jing Wang, Takeshi Ito, Kadriye Nehir Cosgun, Matthew S Davids, Markus Müschen

Blood (2025) 146 (Supplement 1): 437.

https://doi.org/10.1182/blood-2025-437

Published: 2025

Journal Articles

Functional analyses of vitt patient-derived PF4-antibodies and adenoviral vaccine compounds reveal unique patient-specific profiles of multicellular activation

Romy Meier, Carolien Zeelen, Britta Naus, Rinke Bos, Marijn Van der Neut Kolfschoten, Lucy Rutten, Annemart Koornneef, Jing Jing Wang, Tom Gordon, Suzanne Hofstede-van Egmond, Leendert Porcelijn, Masja de Haas, Rick Kapur

Blood (2025) 146 (Supplement 1): 424.

https://doi.org/10.1182/blood-2025-424

Published: 2025

Journal Articles

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy for pediatirc relapsed and Refractory Acute lymphoblastic leukemia followed by TCRαβ-depleted haplo-HSCT

Huaying Liu, Jing Wang, Simeng lv, Zhihao Tang, Haoran Xiao, Yuelin He, Chunfu Li

Blood (2025) 146 (Supplement 1): 2529.

https://doi.org/10.1182/blood-2025-2529

Published: 2025

Journal Articles

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

Changjian Yan, Chaoling Wu, Ping Yang, Xiaoyu Hao, Jie Chen, Jing Wang, Mingxia Zhu, Yan Liu, Hongmei Jing, Weilong Zhang

Blood (2025) 146 (Supplement 1): 1821.

https://doi.org/10.1182/blood-2025-1821

Published: 2025

Journal Articles

Data update of a single-arm, Phase II Study of orelabrutinib with/without Rituximab in patients with chronic lymphocytic leukemia/small Lymphocytic Lymphoma after BTK inhibitor therapy

Blood (2025) 146 (Supplement 1): 7416.

https://doi.org/10.1182/blood-2025-7416

Published: 2025

Journal Articles

Golidocitinib combined with CHOP in treatment-Naïve monomorphic epitheliotropic intestinal T-cell lymphoma: Preliminary results from A phase 2 multicenter, single-arm goal study

Yu-Ran Qiu, Ming-Ci Cai, Wenyu Li, Haiyan Yang, Jing Wang, Li Wang, Wei Li Zhao

Blood (2025) 146 (Supplement 1): 3649.

https://doi.org/10.1182/blood-2025-3649

Published: 2025

Journal Articles

Safety and efficacy of aponermin-based chemotherapy as bridging therapy before CAR-T cell treatment in relapsed/refractory multiple myeloma

Huanxin Zhang, Yi Wang, Chengcheng Fu, Yanli Feng, Yang Liu, Jing Wang, Chunrui Li, Wenming Chen, Zhenyu Li

Blood (2025) 146 (Supplement 1): 2270.

https://doi.org/10.1182/blood-2025-2270

Published: 2025

Journal Articles

The efficacy of Obinutuzumab , zanubrutinib combined with pomalidomide and Venetoclax for the treatment of high-risk mutated Mantle Cell Lymphoma (MCL): A prospective, open-label, single-arm study

Ping Yang, Jinjie Gao, Lan Luo, Weilong Zhang, Jing Wang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 1530.

https://doi.org/10.1182/blood-2025-1530

Published: 2025

Journal Articles

A novel protocol of dual passing cord blood pre-/post-transplant reduced relapse in TCRαβ cell depleted HCT

Huaying Liu, Zhiyong Peng, Yuanying Zeng, Weiwei Zhang, Jing Wang, Zhaoke Bu, Sa Zong, Yuelin He, Chunfu Li

Blood (2025) 146 (Supplement 1): 6062.

https://doi.org/10.1182/blood-2025-6062

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Co-mutation of BCOR and BCORL1 was associated with favorable outcome in the adverse risk patients with Acute Myeloid Leukemia

Orelabrutinib combined with short-course bendamustine-rituximab (BR) for first-line treatment of chronic lymphocytic leukemia: A prospective multicenter study

JAK1/2 inhibition with ruxolitinb potentiates ex vivo activity of epcoritamab in primary CLL cells

CD47-blockade induces programmed necroptosis and complements the effects of BCL-2 inhibition in lymphoid malignancies

Phase I study of a CD19-directed CAR-T cell therapy for Relapsed/refractory mantle cell lymphomas(MCL)

Efficacy and safety of first-line orelabrutinib combined with obinutuzumab (With or Without Bendamustine) in high-risk marginal zone lymphoma: Results from the orchid study

Genomic characterization uncovers molecular subtypes in Mantle Cell Lymphoma

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma

Efficacy and safety of iptacopan in paroxysmal nocturnal hemoglobinuria (PNH): A real-world study of 35 patients from anhui, China

Inhibition of PRMT5 with JNJ-64619178 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptosis

Efficacy and safety of zanubrutinib combined with reduced-dose bendamustine and Rituximab for eldly Mantle Cell Lymphoma: A retrospective analysis

Apoptotic rewiring via PI3K hyperactivation as a therapeutic strategy in B-cell malignancies

Functional analyses of vitt patient-derived PF4-antibodies and adenoviral vaccine compounds reveal unique patient-specific profiles of multicellular activation

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy for pediatirc relapsed and Refractory Acute lymphoblastic leukemia followed by TCRαβ-depleted haplo-HSCT

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

Data update of a single-arm, Phase II Study of orelabrutinib with/without Rituximab in patients with chronic lymphocytic leukemia/small Lymphocytic Lymphoma after BTK inhibitor therapy

Golidocitinib combined with CHOP in treatment-Naïve monomorphic epitheliotropic intestinal T-cell lymphoma: Preliminary results from A phase 2 multicenter, single-arm goal study

Safety and efficacy of aponermin-based chemotherapy as bridging therapy before CAR-T cell treatment in relapsed/refractory multiple myeloma

The efficacy of Obinutuzumab , zanubrutinib combined with pomalidomide and Venetoclax for the treatment of high-risk mutated Mantle Cell Lymphoma (MCL): A prospective, open-label, single-arm study

A novel protocol of dual passing cord blood pre-/post-transplant reduced relapse in TCRαβ cell depleted HCT

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only